// App-Quantinova.ai

1817 : A novel non-secosteroidal VDR agonist, VDRM2, inhibits prostate tumor growth

Researchers

Presenter

  • Justin Roberts

Principal Investigators

  • James MacKrell

  • D B. Piyarathna

  • Gary Krishnan

  • Cristian Coarfa

  • David Rowley

  • Nancy L. Weigel

Medical Centers

  • Baylor College of Medicine, Houston, TX

  • Lilly Research Laboratories, Indianapolis, IN.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Hypercalcaemia

  • Solid malignancies

Biomarkers

  • cMYC

  • Cytochrome P450 family 24 subfamily A member 1

  • ETS transcription factor ERG

  • Transmembrane Serine Protease 2

Drug/Treatment

  • Ergocalciferol

  • Androgen Tear

  • Seocalcitol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved